GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Channel Therapeutics Corp (AMEX:CHRO) » Definitions » Additional Paid-In Capital

CHRO (Channel Therapeutics) Additional Paid-In Capital : $19.25 Mil(As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Channel Therapeutics Additional Paid-In Capital?


Channel Therapeutics's quarterly additional paid-in capital increased from Sep. 2024 ($18.12 Mil) to Dec. 2024 ($18.76 Mil) and increased from Dec. 2024 ($18.76 Mil) to Mar. 2025 ($19.25 Mil).

Channel Therapeutics's annual additional paid-in capital increased from Dec. 2022 ($2.43 Mil) to Dec. 2023 ($7.08 Mil) and increased from Dec. 2023 ($7.08 Mil) to Dec. 2024 ($18.76 Mil).

Channel Therapeutics Additional Paid-In Capital Historical Data

The historical data trend for Channel Therapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Channel Therapeutics Additional Paid-In Capital Chart

Channel Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
- - 2.43 7.08 18.76

Channel Therapeutics Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.21 17.67 18.12 18.76 19.25

Channel Therapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Channel Therapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Channel Therapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Channel Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Channel Therapeutics Corp (AMEX:CHRO) » Definitions » Additional Paid-In Capital
Comparable Companies
APM AIMI KLTO ENZN IBO ACUT LYRA AEON CNSP CDIO VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
4400 Route 9 South, Suite 1000, Freehold, NJ, USA, 07728
Website
https://www.channeltherapeutics.com
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.